Former Estee Lauder chair tells INTA sea stories

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Former Estee Lauder chair tells INTA sea stories

“In the Navy you don’t learn from textbooks, you have sea stories instead,” Leonard A. Lauder told attendees in his keynote speech at the opening ceremony yesterday. The Chairman Emeritus of The Estée Lauder Companies, Lauder joined his parents’ company in 1958 when he left the US Navy. “I looked pretty sexy in that Navy uniform,” he remembered.

With affecting honesty and humor, Lauder told several of these “sea stories” about the Estée Lauder brands, their successes and failures, in the hope of revealing some lessons for attendees: “In the 1950s there was a saying among advertising executives—the kind you see in the television series Mad Men today. They used to say: ‘Let’s get down on all fours and look at this from the client’s perspective.’ Well here goes,” he said.

The first story described the launch of beauty brand Clinique in 1968. The company and its lawyers had searched thoroughly for similar trademarks and, satisfied there was nothing similar out there, went ahead with production. But a month before launch, the lawyers phoned to say there had been a complaint from a product called Astringent Clinique. “We looked under ‘C’ but we forgot to look under ‘A’,” said Lauder.

The mark was registered by a magazine called Cat Fancy. Lauder went to talk to the owner, who asked for 5% of Clinique’s revenues in payment. The company paid $100,000 over five years instead—which has proven to be a wise decision, given Clinique’s growth. “I adore that trademark and I think the lesson is: you can never be too careful,” Lauder told the audience.

He loved another brand, Origins, so much that he bought the company. But a shop in Santa Fe, New Mexico, sued, claiming Lauder and his wife had been into the shop, liked the name and launched the brand to copy it. “Now I had bought Origins two years before this woman (who cried a lot!) claimed I had gone in. But did that make me right? My lawyers advised me that I would win eventually, but only after I had lost to a jury and appealed a couple of times. It was much cheaper to settle, so we did, and I’ve been glad ever since. Being right is one thing, but living well is another. And I like living,” Lauder told the audience, to a round of applause.

So what was the lesson from that experience? “As a lawyer it’s your job to convince clients that they don’t have to win every time. They are probably very successful, they probably win at business, at golf, at everything. You need to tell them not to spend all their money on you, just to be right.”

more from across site and SHARED ros bottom lb

More from across our site

AG Barr acquires drinks makers Fentimans and Frobishers, in deals worth more than £50m in total
Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Gift this article